Central Nervous System - Best of ASTRO 2019
There has been a recent flurry of practice-changing options for managing brain and spine metastases as a result of refinements in pathological classification of tumors, better systemic management options, improved imaging permitting precise localization of pathology and avoidance structures within the brain and spine, and better radiotherapy technology. Optimal management of individual patients requires the integration of knowledge across a range of disciplines and an understanding of situations for which clinical trials have not yet provided definitive answers.
This activity is available from November 16, 2019, through 11:59 p.m. Eastern time on November 15, 2022.
This activity was originally recorded at ASTRO’s 2019 Best of ASTRO, November 14-16, 2019 in Washington, DC.
The activity is designed to meet the interests of radiation oncologists and radiation oncology residents.
- Select radiation approaches for patients with painful (but stable) spine metastases and brain metastases
- Identify patients with low-grade gliomas who should not receive PCV chemotherapy after partial brain irradiation
- Counsel patients and other healthcare professionals about the expected outcomes from salvage radiation with concomitant bevacizumab for recurrent glioblastoma
Jonathan Knisely, MD, FASTRO is employed at Weill Cornell Medicine and has no other disclosures.
The person(s) above served as the developer(s) of this activity. Additionally, the Education and CME/MOC Committees had control over the content of this activity.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
- 1.00 Certificate of AttendanceThis activity was designated for 1.00 AMA PRA Category 1 Credit™.
- 1.00 SA-CME
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.
The American Society for Radiation Oncology (ASTRO) designates this Enduring material for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.00 self-assessment credits.
ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.
- Nonmember: $105
- Member: $55
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.
Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.
The course and its materials will only be available on the ASTRO website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.